Stock comparison
LeMaitre Vascular
Smith & Nephew
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
SNN
Smith & Nephew
Market cap
$13.01B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LMAT | SNN | Winner |
|---|---|---|---|
| Warren Buffett | 77B | 54C | LMAT |
| Benjamin Graham | 89A | 68B | LMAT |
| Philip Fisher | 81C | 45D | LMAT |
| Peter Lynch | 67B | 57C | LMAT |
| Joel Greenblatt | 56D | 33F | LMAT |
| Charlie Munger | 68D | 47D | LMAT |
| Terry Smith | 69D | 49D | LMAT |
Side-by-side metrics
| Metric | LMAT | SNN |
|---|---|---|
| Market cap | $2.23B | $13.01B |
| P/E (TTM) | 37.1x | 20.3x |
| EV/EBIT | 36.6x | 15.5x |
| ROIC (TTM) | 9.43% | 9.11% |
| Gross margin | 72.39% | 68.01% |
| Net margin | 24.35% | 10.14% |
| Revenue CAGR 5y | 12.75% | 4.34% |
| EPS CAGR 5y | 19.04% | 5.03% |
| Debt / Equity | 0.5x | 0.6x |
| Dividend yield | 0.84% | 2.62% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LMAT leads on
- EPS CAGR 5y19.04%vs 5.03%+74%
- Revenue CAGR 5y12.75%vs 4.34%+66%
- Net margin24.35%vs 10.14%+58%
- Debt / Equity0.5xvs 0.6x+26%
SNN leads on
- Market cap$13.01Bvs $2.23B+83%
- Dividend yield2.62%vs 0.84%+68%
- EV/EBIT15.5xvs 36.6x+58%
- P/E (TTM)20.3xvs 37.1x+45%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.